Delivery Order SPE2DB25D3201-SPE2DB26FNNPN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count unit) with a ceiling value of $1,487.88. This non-set-aside, firm fixed-price delivery order is scheduled for completion by October 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Duloxetine HCL DR 60 mg capsules (1,000 units) with a ceiling value of $3,245.94. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 25, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count packaging) with a ceiling value of $1,320.72. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The order has an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,084.80 to AmerisourceBergen Drug Corp for Duloxetine HCL DR 40 mg capsules (30-count) on August 15, 2025, with completion expected by August 18, 2025. This firm fixed-price, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a routine pharmaceutical procurement fulfilling federal medical...
- The Defense Logistics Agency awarded a $1,170.96 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Duloxetine HCL DR 60 mg capsules (1,000 units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set for completion by September 2, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units) valued at $1,979.60. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction. The order is scheduled for ultimate completion by September 16, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,376.36 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units). This contract utilizes a firm fixed-price structure and is not set aside for any particular business category. The award is classified as a delivery order, indicating it derives from an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Duloxetine HCL DR 60 mg capsules (1,000 count) with a ceiling value of $2,007.74. This firm fixed-price delivery order, which is expected to be completed by September 25, 2025, utilizes no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a straightforward pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of 1,000 units of Duloxetine HCL DR 60 mg capsules, valued at $1,046.72. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count packaging) with a ceiling value of $1,882.44. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 29, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNPNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (90-count units) valued at $3,416.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 24, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the open competition procurement process. This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying an extensive range of medications and medical supplies to support military and veteran healthcare systems worldwide. The Duloxetine HCL supply fulfills the Defense Health Agency and other federal healthcare system requirements for this neurological treatment medication.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 10/23/25 |